To test this hypothesis, we isolated both TAMs (CD45+/F4/80+ cells) and non-immune stromal cells (CD45-/zsGreen-) using FACS from established orthotopic PDAC tumours that had been treated with either IgG2 control antibody or IGF-blocking antibody (Figure 3H). This evidence concerns the gene PTPRC and neoplasm.